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ABSTRACT Because cigarette smoking is a definite risk for the development of cardiovascular 
disease and nicotine induced vasoconstriction may be a possible pathogenetic factor the haemodyna- 
mic effects of smoking cigarettes with high or low nicotine content were compared with those induced 
by chewing nicotine gum in a placebo controlled, crossover study in six healthy volunteers. The three 
stimuli induced similar increases in heart rate (about 20%) and systolic blood pressure (about 7%) and 
a decrease in digital blood flow. Although the mean haemodynamic changes parallelled the mean 
plasma nicotine concentration increases, no correlation was found between them when the individual 
values were considered. It is concluded that the nicotine induced haemodynamic changes probably 
occur as a result of the (local) release of vasoactive mediators such as adrenaline or noradrenaline after 
a threshold plasma nicotine concentration has been reached. Such a threshold may explain the large 
interindividual variability in susceptibility to smoking induced cardiovascular diseases. 
Epidemiological studies have established a clear 
relation between cigarette smoking and cardiovascular 
diseases such as myocardial infarction’ and peripheral 
arterial occlusive disease.’ However. the pathogenesis 
of these smoking induced cardiovascular events is not 
completely understood. Several mechanisms have 
been proposed. including vasospasm due to ( a )  
nicotine induced release of adrenergic 
cat echo la mine^,^ thus producing vasoconstriction and 
increased heart rate; (b )  increased release of the 
vasoconstrictor thromboxane A2 and a reduction of the 
endothelial production of prostacyclin, a potent 
vasodilator and platelet antiaggregating 
and (c)  increase of the carboxyhaemoglobin content of 
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blood with a possible decrease of the oxygen supply to 
the endothelial cell.’ 
In the present study, we compared the 
haemodynamic response of young healthy smokers to 
three different nicotine stimuli: a cigarette with high or 
low nicotine content and a nicotine chewing gum. 
These three stimuli were compared with a placebo in a 
crossover study,8 and the induced haemodynamic 
changes were correlated with increases in the plasma 
nicotine concentration. 
Subjects and methods 
STUDY PROTOCOL 
Six healthy male smokers (mean(SD) age 30(2.8) 
years; mean(SD) cigarette consumption 8.2 (1.1) pack 
year, where 1 pack year corresponds to smoking 1 
pack of 20 cigarettes per day during one year) were 
enrolled in a crossover, placebo controlled study. The 
trial was carried out according to the Declaration of 
Helsinki and was approved by the human ethical 
committee of our institution. The study consisted of 
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four periods, which were separated from each other by 
at least 24 h. Smoking or chewing was prohibited 
during the 12 hours preceding each period. The 
sequence of the following four periods was 
randomised: smoking (in 5 min) a filter cigarette 
containing 1.2 or 0.1 mg of nicotine or chewing 
(during 45 min) a gum containing 4 mg of nicotine or 
an ordinary arabic gum. 
EXPERIMENTAL PROCEDURE 
Before the start of each period volunteers lay for at 
least 20 min in a room at a constant temperature 
(22°C). A butterfly needle was inserted in an 
antecubital vein of the right arm through which 5% 
glucose was slowly infused (about 1 mlmin-'). A 
sphygmomanometer cuff was placed around the right 
arm and humeral systolic (SBP) and diastolic (DBP) 
blood pressure and heart rate (HR) were recorded at 5 
min intervals using an automatic device (Accutor, 
Datascope Corp, New Jersey). Digital blood flow (BF) 
was measured every 5 min in the left third finger, the 
arm being raised to heart level, using venous occlusion 
plethysmography. Briefly, a cuff was placed around 
the proximal phalanx of the finger and a mercury strain 
gauge around the distal phalanx. The cuff was then 
rapidly inflated to 50 mmHg. The digital blood flow 
was derived from the slope of the initial increase of the 
finger volume after cuff inflation and expressed in 
mlmin-' per 100 ml tissue. The peripheral vascular 
resistance (PVR) was then calculated using the 
following formula': 
PVR=(SBP+2 DBP)/3 BF 
and expressed in arbitrary units (AU). A thermistor 
probe was fixed on the second finger of the left hand 
for measuring skin temperature and an electrode 
attached to the dorsum of the left foot for recording 
transcutaneous partial oxygen tension" at 5 min 
intervals. All measurements were carried out for 45 
min from the start of smoking or chewing. 
Blood samples were taken by the double syringe 
technique just before the start of each period and after 
5 ,  30, and 45 min in tubes containing lithium 
heparinate for measuring whole blood 
carboxyhaemoglobin and plasma nicotine 
concentration. The carboxyhaemoglobin content of 
venous blood was measured within 30 min of sampling 
using a CO-oxymeter (Corning 2500, CIBA-Corning , 
Switzerland). Plasma was obtained by centrifugation 
of the heparinised blood at 3000 g for 10 min. Aliquots 
were stored at -20°C until the assay for nicotine was 
performed by gas liquid chromatography. I ' 
ANALYSIS OF THE DATA 
Using a method previously described," the values of 
blood flow and peripheral vascular resistance were log 
transformed to obtain a normal distribution. For each 
variable, the area under the curve (AUC) was 
calculated for the 45 min period of observation. These 
values were compared by one way analysis of 
variance. Linear regression analysis was used to study 
correlations between the changes in the various 
haemodynamic variables and the increases in the 
plasma nicotine concentrations using the AUC values. 
Unless stated otherwise, all values are given as 
mean(SEM). 
Results 
Both cigarette smoking and nicotine gum chewing 
were associated with increases of systolic blood 
pressure (fig la) (p<0.05) and heart rate (fig Ib) 
(p<O.001) compared with placebo. The maximal 
increase of systolic blood pressure was 9%, 4%, and 
7% of the baseline value for the cigarette with high or 
low nicotine content and for the nicotine gum 
respectively. The corresponding figures for the 
maximal increase of heart rate were 25%, 18%, and 
25%. A significant decrease (p<0.05) in digital blood 
flow (fig lc) during the 45 min observation period was 
recorded only after smoking the cigarette with high 
nicotine content. A similar trend (0,05<p<O. 1) was 
also observed with the nicotine gum, whereas no 
significant change in blood flow was seen after 
smoking the cigarette with low nicotine content. 
Although considerable increases in calculated 
peripheral vascular resistance were obtained (fig Id), 
they did not reach the level of statistical significance 
because of the large interindividual variations in the 
response to the different stimuli. Whereas the maximal 
haemodynamic changes were seen very early (at 5 
min) after cigarette smoking they occurred between 10 
and 20 min after nicotine gum chewing. With the 
latter, the maximal decrease in digital blood flow was 
not reached even after 45 min. 
No consistent changes in skin temperature or 
transcutaneous partial oxygen tension were observed 
with the different stimuli (data not shown). 
The maximal increase in plasma nicotine 
concentration (fig 2a) was obtained after 5 min with 
the two cigarettes (87(22) nmo1.lih-e-I and 62(24) 
nmol.litre-' after the cigarette with high or low 
nicotine content respectively (NS)). The 
corresponding figure was 55(8) nmol.litre-' for the 
nicotine gum after 45 min. 
The increases in nicotine concentrations over the 45 
min observation period did not differ statistically from 
each other for the three nicotine stimuli. The 
carboxyhaemoglobin content of whole blood 
increased significantly after both cigarettes compared 
with the nicotine gum and placebo (fig 2b). The 
increase was significantly more pronounced 
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(p<O.OOl) after the cigarette with high nicotine 
content than after that with the low nicotine content. 
N o  significant correlation was found between either 
change in the haemodynamic values and the increase 
in plasma nicotine concentration. 
Discussion 
In the present study cigarette smoking and chewing 
nicotine gum induced notable and long lasting in- 
creases in systolic blood pressure and heart rate in 
healthy humans. A decrease in digital blood flow was 
also observed after smoking a cigarette with high 
nicotine content and during chewing nicotine gum. 
However, the latter change was not statistically 
significant. The absence of any haemodynamic effect 
during chewing the ordinary arabic gum eliminates the 
possibility of a non-specific reaction. Although the 
time course of these changes suggested a close relation 
with the increase in plasma nicotine concentration, no 
significant correlation was found between changes in 
any haemodynamic variable and the increases in 
plasma nicotine concentration, when the individual 
values were considered. 
There are two main limitations in our study design. 
Firstly, with the timing that we used for the plasma 
nicotine measurements and the haemodynamic assess- 
ments, it is possible that the peak nicotine concentra- 
tion during cigarette smoking or the maximal 
haemodynamic changes or both were not recorded. 
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FIG 2 
concentrations after smoking or chewing (A) ordinary 
arabic gum (placebo), (A) nicotine gum, (0) cigarette with 
high nicotine content. or (0) cigarette with low nicotine 
content. 
Nicotine (a )  and carboxyhaemoglobin (b)  
However, the reported absorption kinetics of nicotine 
after buccal administration or cigarette smoking13 
suggest that the magnitude of such an error would be 
very small and could not account for the total absence 
of a correlation which we observed between the 
individual increases in plasma nicotine concentration 
and the haemodynamic changes. Secondly, the study 
was conducted on only six subjects. Although the 
double blind, crossover design is very powerful,' 
statistical significance could not always be reached 
because of the large interindividual variations of the 
response to the different stimuli - especially digital 
blood flow and derived value of peripheral vascular 
resistance - and this was probably due to the small 
sample size. 
However, our observations suggest that the nicotine 
induced haemodynamic effects occur as a result of 
mediators when the plasma concentration of nicotine 
has reached a threshold level. Such a threshold level 
might be characteristic for a given individual and 
might explain, at least partly, the large interindividual 
variability in susceptibility to smoking induced car- 
diovascular diseases. 
It has been suggested that catecholamines, which 
are released locally from adrenergic nerve terminals, 
could be responsible for these haemodynamic 
 reaction^.^ Recently, Winniford and colleagues de- 
monstrated in long term smokers with atherosclerotic 
coronary artery disease that the smoking induced 
vasoconstriction was due to a primary alpha adrenergi- 
cally mediated increase in coronary artery tone. l4 
Apart from such an increase in alpha adrenergic tone, 
smoking may induce vasoconstriction in other ways. 
Stimulation of the secretion of arginine vasopressin, a 
powerful vasoconstrictor, has been observed, l 5  but the 
alterations in coronary blood flow caused by smoking 
do not seem to be related to the smoking induced 
changes in plasma arginine vasopressin.16 A role of 
arachidonic acid metabolites has also been proposed; 
smoking may induce the release of the potent vasocon- 
strictor thromboxane A2 from platelets4 and a diminu- 
tion of the release of the vasodilator prostacyclin.6 
However, these eicosanoids were not modified in 
coronary sinus blood during smoking induced 
vasoconstriction.' In addition, their role in the media- 
tion of the cold induced vasoconstriction has also been 
questioned.12 On the other hand, the plasma nicotine 
concentration increase with the high nicotine and low 
nicotine cigarettes was not statistically different at 
p<0.05, although the nicotine content of the cigarettes 
was quite different, 0.1 and 1.2 mg, as given by the 
manufacturer. If these contents are assumed to be 
correct, it may be that the filter abolishes the differ- 
ence. However, the two cigarettes produced haemody- 
namic effects that did not differ statistically from each 
other. The digital blood flow, however, was less 
affected by the low nicotine cigarette than by the high 
nicotine cigarette. 
Another finding of our study was that a gum 
containing 4 mg of nicotine induced haemodynamic 
changes which were of the same order of magnitude as 
those caused by smoking a cigarette with a high 
nicotine content. The only difference was the delayed 
response, which can be explained by the delayed oral 
absorption. j 3  The maximal effects were observed at 
the end of the 45 min observation period while at the 
same time the effects caused by smoking had almost 
disappeared. Thus nicotine gum should be useful for 
only a short time for overcoming the withdrawal 
symptoms that occur when stopping smoking. 
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Correction 
In the paper by Furukawa e t a /  (1987;21:717-724) the 
footnote to the table on p 720 should have read as 
follows: *p>O.OS, **p<O.OS, ***p<0.005, 
****p<O.OOl vs values at 30 s during each stimula- 
tion. tp>O.OS, f t t p t O . 0 0 5 ,  t t t t p t 0 . 0 0 1  1's values 
at 30 s during sympathetic stimulation. 
